{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:59:41Z","timestamp":1794373181479,"version":"4.9.0"},"reference-count":137,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2023,8,3]]},"DOI":"10.1080\/17425247.2023.2261369","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T14:50:23Z","timestamp":1695307823000},"page":"1097-1113","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Inhalation delivery of nucleic acid gene therapies in preclinical drug development"],"prefix":"10.1080","volume":"20","author":[{"given":"Conor A.","family":"Ruzycki","sequence":"first","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Montoya","sequence":"additional","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad","family":"Irshad","sequence":"additional","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Cox","sequence":"additional","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-3002","authenticated-orcid":false,"given":"Philip J.","family":"Kuehl","sequence":"additional","affiliation":[{"name":"Lovelace Biomedical Research Institute, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,24]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19507-0"},{"key":"e_1_3_5_4_1","unstructured":"Gottlieb S. Statement from FDA commissioner Scott Gottlieb M.D. and Peter Marks M.D. Ph.D. director of the center for biologics Evaluation and research on new policies to advance development of safe and effective cell and gene therapies [Internet]. FDA; 2019 [cited 2023 Apr 25]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/statement-fda-commissioner-scott-gottlieb-md-and-peter-marks-md-phd-director-center-biologics"},{"key":"e_1_3_5_5_1","unstructured":"FDA Office of Tissues and Advanced Therapies (OTAT). Approved cellular and gene therapy products [Internet]. FDA. FDA; 2023 [cited 2023 Apr 25]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/approved-cellular-and-gene-therapy-products"},{"key":"e_1_3_5_6_1","first-page":"58806","article-title":"Food and Drug administration: statement of organization, functions, and delegations of authority","volume":"87","author":"Becerra X.","year":"2022","unstructured":"Becerra X. Food and Drug administration: statement of organization, functions, and delegations of authority. Fed Regist. 2022;87:58806\u201358807.","journal-title":"Fed Regist"},{"key":"e_1_3_5_7_1","unstructured":"Chemistry Manufacturing and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs). Guidance for industry. Docket Number 2008-D-0205. [Internet]. U.S. Departent of Health and Human Services Food and Drug Adminstration. Center for Biologics Evaluation and Research; 2020 [cited 2023 Apr 18]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/chemistry-manufacturing-and-control-cmc-information-human-gene-therapy-investigational-new-drug"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052736"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00439-4"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.11.014"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0075-7"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0207-x"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.199"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.246"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2020.08.002"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00487-6"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-022-00332-7"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.03.024"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.10.061"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040813"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2019.03.007"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2022.2112569"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-022-00363-0"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1385\/MB:23:1:51"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1015926"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes9110538"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.04.008"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581815624080"},{"key":"e_1_3_5_29_1","unstructured":"Preclinical Assessment of Investigational Cellular and Gene Therapy Products. Docket number FDA-2012-D-1038. [Internet]. U.S. Departent of Health and Human Services Food and Drug Adminstration. Center for Biologics Evaluation and Research; 2019 [cited 2023 May 1]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/preclinical-assessment-investigational-cellular-and-gene-therapy-products"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1730807"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113862"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1011143"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2016.1297"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2183771"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30363-5"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.08.012"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2018.1544616"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70072-9"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.05.017"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41120-016-0005-2"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114038"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.06.001"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1214569"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-102749-3.00001-4"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2020.29031.wh"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2016.01.018"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2023.106184"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.05.031"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.09.010"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1712356"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.995087"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24574"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/9783527802104.ch7"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-013-0063-x"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.09.089"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2213-4"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2006.19.372"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1208\/ps040313"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.21493"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2542-y"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2004.11.017"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.77"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10140"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.32.18997"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.11.041"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302076"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(03)00233-8"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12624-4"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2008.08.011"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(00)00085-3"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c15-00615"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultsonch.2022.106088"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.0c00317"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-153"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphys.2021.111192"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c05647"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1201\/b14404-9"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4535-4_1"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2006.19.473"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/02786826.2017.1306640"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/02786826.2016.1262532"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S274846"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2012.0975"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1201\/9781003182566-2"},{"key":"e_1_3_5_86_1","first-page":"1","article-title":"Improved targeting of dry powder formulations of inhaled corticosteroids to children","volume":"2022","author":"Weers JG","year":"2022","unstructured":"Weers JG, Miller DP, Tarara TE. Improved targeting of dry powder formulations of inhaled corticosteroids to children. Respir Drug Deliv. 2022;2022:1\u20138.","journal-title":"Respir Drug Deliv"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2018.1497"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03316-9"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2013.01.008"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2020.105649"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02924-7"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-021-03082-0"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2022.901289"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1201\/b14022-4"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203204"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2021.29033.am"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(90)90003-H"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122661"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00477-9"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03554"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.108"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines1010003"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2019.1641083"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026768"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408449309104076"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1201\/b14404"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00146"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/08958370802207318"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1382-3"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10379"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.10.017"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1089\/humc.2014.154"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7531"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301369"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.1999.0021"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn7162"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00786-x"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805116"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010025"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2009.35"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1089\/hgtb.2018.050"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2002.0632"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047978"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.797"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.049"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.2144\/btn-2019-0150"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.55"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300058"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79855-1"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/55.1.24"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1997.2390"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.8b07524"},{"key":"e_1_3_5_133_1","doi-asserted-by":"crossref","unstructured":"Bush E Nicholas A Pei T et al. Targeting aEnac with an epithelial RNAi trigger delivery platform for the treatment of cystic fibrosis. Eur Respir J. 2018;52:p. OA514.","DOI":"10.1183\/13993003.congress-2018.OA514"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2014.147"},{"key":"e_1_3_5_135_1","unstructured":"Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products. Docket Number FDA-2014-D-0852. [Internet]. U.S. Departent of Health and Human Services Food and Drug Adminstration. Center for Biologics Evaluation and Research; 2019 [cited 2023 May 18]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/design-and-analysis-shedding-studies-virus-or-bacteria-based-gene-therapy-and-oncolytic-products"},{"key":"e_1_3_5_136_1","unstructured":"U.S. Pharmacopeia. General chapter <601> inhalation and nasal Drug products: aerosols sprays and powders - performance quality tests. USP-NF. Rockville (MD): Untied States Pharmacopeia; 2023."},{"key":"e_1_3_5_137_1","unstructured":"U.S. Pharmacopeia. General chapter <1601> products for nebulization - characterization tests. USP-NF. Rockville (MD): Untied States Pharmacopeia; 2023."},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2015.1241"},{"key":"e_1_3_5_139_1","volume-title":"Ph Eur 9.8 general chapter 2.9.44 preparations for nebulization - characterization","author":"European Pharmacopeia","year":"2019","unstructured":"European Pharmacopeia. Ph Eur 9.8 general chapter 2.9.44 preparations for nebulization - characterization. Strasbourg (France): Directorate for the Quality of Medicines and HealthCare of the Council of Europe (EDQM); 2019."},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01679-x"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2023.2261369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:44:45Z","timestamp":1727268285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2023.2261369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":137,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,3]]}},"alternative-id":["10.1080\/17425247.2023.2261369"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2023.2261369","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}